Synthetic vs digital 2D mammograms in assessing breast tissue density.
Despite some reader variability, synthetic 2D mammography is comparable with digital 2D mammography to assess breast tissue density, according to a study published in the American Journal of Roentgenology.
Researchers from the University of Virginia Health System in Charlottesville performed a retrospective study to compare assessments of breast density between synthetic and digital 2D mammograms. Images from 309 patients were included in the study. All had undergone screening with digital 2D mammography and tomosynthesis during May 2015 with a negative or benign outcome.
Three radiologists with five to 25 years of clinical experience and one year of experience with synthetic 2D mammography read the digital 2D and synthetic 2D images in separate reading sessions, and assigned breast density categories according to the 5th edition of BI-RADS.
The results showed agreement between consensus BI-RADS density categories assigned for digital and synthetic 2D mammography was 80.3% and for combined dense and nondense categories, agreement reached 91.9%. For consensus readings, similar numbers of patients were shifted between nondense (11) and dense categories (14) with the synthetic 2D compared with digital 2D mammography.
The differences between readers were apparent; assignment to dense categories was greater with digital 2D mammography for reader 1 and for reader 2, but greater with synthetic 2D mammography for reader 3.
The researchers concluded that overall, synthetic 2D mammography was comparable with digital 2D mammography in assessment of breast density. They did note some variability by reader. “Practices can readily adopt synthetic 2D mammography without concern that it will affect density assessment and subsequent recommendations for supplemental screening,” they wrote.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
New Research Examines Socioeconomic Factors with Mammography No-Shows
April 10th 2024Patients with Medicaid or means-tested insurance were over 27 percent more likely to miss mammography appointments, and only 65 percent of women with three of more adverse social determinants of health had a mammography exam in a two-year period covering 2020 and 2021, according to new research and a report from the CDC.
Mammography Study: AI Improves Breast Cancer Detection and Reduces Reading Time with DBT
April 3rd 2024An emerging artificial intelligence (AI) model demonstrated more than 12 percent higher specificity and reduced image reading time by nearly six seconds in comparison to unassisted radiologist interpretation of digital breast tomosynthesis (DBT) images.